NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Equipment

12 Months Ended

Sep. 30, 2022

4. Equipment

The Company’s equipment consisted of the following:


	As of September 30,		As of September 30,		Estimated useful life
	2022		2021		(in years)
Laboratory equipment	$	3,175,019	$	2,737,390	5
Office equipment		259,978		259,978	3
Leasehold improvements		17,958		—	5
Total		3,452,955		2,997,368
Accumulated depreciation and amortization		(1,296,104)		(533,486)
Equipment, net	$	2,156,851	$	2,463,882

Depreciation and amortization expense for the years ended September 30, 2022 and 2021 was approximately $0.8 million and $0.4 million, respectively.